CIK: 0001807489 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 12, 2022
Total Value ($000): $89,205 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES LTD | 8,282,204 | $26,917 | 30.2% | $3.07 | -37.3% | SHS | Y95308105 |
| IVVD | ADAGIO THERAPEUTICS INC | 6,398,250 | $20,986 | 23.5% | $23.72 | -86.8% | COM | 00534A102 |
| RCKT | ROCKET PHARMACEUTICALS INC | 715,880 | $9,851 | 11.0% | $24.20 | -50.7% | COM | 77313F106 |
| STOK | STOKE THERAPEUTICS INC | 527,150 | $6,964 | 7.8% | $23.86 | -36.3% | COM | 86150R107 |
| BBIO | BRIDGEBIO PHARMA INC | 466,200 | $4,233 | 4.7% | $42.31 | -80.2% | COM | 10806X102 |
| — | CURIS INC | 4,243,293 | $4,178 | 4.7% | $3.84 | — | COM NEW | 231269200 |
| — | MIRATI THERAPEUTICS INC | 61,200 | $4,108 | 4.6% | $97.15 | — | COM | 60468T105 |
| TGTX | TG THERAPEUTICS INC | 726,200 | $3,086 | 3.5% | $18.81 | -66.8% | COM | 88322Q108 |
| — | LEAP THERAPEUTICS INC | 2,664,400 | $3,064 | 3.4% | $2.31 | — | COM | 52187K101 |
| — | VERVE THERAPEUTICS INC | 178,500 | $2,727 | 3.1% | $22.82 | — | COM | 92539P101 |
| — | ATARA BIOTHERAPEUTICS INC | 269,253 | $2,097 | 2.4% | $15.76 | — | COM | 046513107 |
| PRQR | PROQR THERAPEUTICS N V | 1,001,800 | $779 | 0.9% | $3.35 | -77.7% | SHS EURO | N71542109 |
| — | NEXIMMUNE INC | 133,442 | $215 | 0.2% | $4.61 | — | COM | 65344D109 |